CardiologyOnline.net

Cardiology Xagena

Xagena Mappa
Medical Meeting
Xagena Salute
Ematobase.it

Search results for "Venous thromboembolism"

FDA ( Food and Drug Administration ) approved the supplemental New Drug Application (sNDA) for Arixtra ( Fondaparinux ) in the prevention of venous thromboembolism ( VTE ) in patients undergoing abd ...


The Phase III EINSTEIN-DVT clinical trial of the oral anticoagulant Rivaroxaban ( Xarelto ) demonstrated non-inferiority compared to the standard of care for the prevention of recurrent venous thrombo ...


Results from the phase III STARS J-V ( Studying Thrombosis After Replacement Surgery ) study have shown Edoxaban ( Lixiana ), a direct factor Xa inhibitor, to be superior to Enoxaparin ( Lovenox ) in ...


The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion recommending a variation to the terms of the marketing authorisation for the medicinal product Xarelto ( Riva ...


Apixaban ( Eliquis ), an oral factor Xa inhibitor administered in fixed doses, may simplify the treatment of venous thromboembolism.In the randomized, double-blind study ( AMPLIFY ), researchers have ...


Results of a pre-specified secondary analysis of the Eliquis Phase 3 AMPLIFY-EXT trial ( Apixaban after the initial Management ofPuLmonary embolIsm and deep vein thrombosis with First-line therapY-EXT ...


Non-vitamin K antagonist oral anticoagulants ( NOACs ) are efficacious and safe antithrombotic drugs but the non-availability of an antidote for potential fatal haemorrhagic events is clinically perce ...


Historically, Warfarin ( Coumadin ) or Acetylsalicylic acid ( Aspirin ) have been the recommended therapeutic options for the extended treatment ( more than 3 months ) of venous thromboembolism ( VTE ...


Findings from a real-world data analysis of the U.S. Medicare database comparing the risk of stroke or systemic embolism and rate of major bleeding among patients with non-valvular atrial fibrillation ...


Compared with traditional chemotherapy, targeted cancer therapy is a novel strategy in which key molecules in signaling pathways involved in carcinogenesis and tumor spread are inhibited. Targeted ca ...